Skip to content

Janux Therapeutics JANX Market capitalization

Market capitalization at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$588.76B+47.3%
Amgen logo
AmgenAMGN
$189.67B+13.3%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.68B+17.8%
Xencor logo
XencorXNCR
$884.46M+18.0%
AbbVie logo
AbbVieABBV
$384.69B+3.8%
Vor Biopharma logo
Vor BiopharmaVOR
$871.44M+873%

Other financials

Income statement

See full
Revenue$3.7M
Operating income-$34.2M+2.0%
Net income-$24.4M-3.6%
EPS (diluted)-$0.39-2.6%

Balance sheet

See full
Cash & equivalents$51.8M-29.7%
Total debt$21.6M-4.6%
Total equity$941.5M-7.0%
Total assets$1.0B-2.1%

Cash flow

See full
Operating cash flow-$12.3M+27.5%
CapEx$273.0K-26.4%
Free cash flow-$12.6M+27.5%

Valuation

See full
Enterprise value$862.55M-35.9%
P/S65×-84.6×

Profitability

See full
Operating margin-1,143.1%-65.1pp
Net margin-833.6%+0.9pp
FCF margin-571.6%+98.3pp

Returns & leverage

See full
Return on equity-11.7%+4.1pp
Debt / equity0.0×
Current ratio17×-41.5×

Where this comes from

Computed from the period-end share price: $845.56M.

The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Janux Therapeutics's market capitalization?
Janux Therapeutics (JANX) reported market capitalization of $845.56M in Q1 2026.
How has Janux Therapeutics's market capitalization changed year-over-year?
Janux Therapeutics's market capitalization decreased by 47.0% year-over-year, from $1.6B to $845.56M.
What is the long-term trend for Janux Therapeutics's market capitalization?
Over 4 years (2021 to 2025), Janux Therapeutics's market capitalization has grown at a 0.5% compound annual growth rate (CAGR), from $815.15M to $830.04M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.